Equity
AOCI
West Pharmaceutical Services AOCI decreased by 18.7% to -$125.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 39.1%, from -$205.50M to -$125.20M. Over 5 years (FY 2020 to FY 2025), AOCI shows relatively stable performance with a -0.9% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ4 2015
Last reportedQ1 2026
How to read this metric
Fluctuations often signal changes in foreign exchange rates, interest rate environments, or pension funding status.
Detailed definition
Accumulated Other Comprehensive Income (AOCI) captures the cumulative unrealized gains and losses that are excluded from...
Peer comparison
Standard equity component for large multinational corporations with complex balance sheets.
Metric ID:
aociHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$133.20M | -$155.70M | -$159.60M | -$182.40M | -$245.90M | -$308.50M | -$183.00M | -$168.40M | -$183.50M | -$223.00M | -$143.80M | -$192.30M | -$216.90M | -$136.30M | -$258.10M | -$205.50M | -$88.70M | -$102.30M | -$105.50M | -$125.20M |
| QoQ Change | — | -16.9% | -2.5% | -14.3% | -34.8% | -25.5% | +40.7% | +8.0% | -9.0% | -21.5% | +35.5% | -33.7% | -12.8% | +37.2% | -89.4% | +20.4% | +56.8% | -15.3% | -3.1% | -18.7% |
| YoY Change | — | — | — | — | -84.6% | -98.1% | -14.7% | +7.7% | +25.4% | +27.7% | +21.4% | -14.2% | -18.2% | +38.9% | -79.5% | -6.9% | +59.1% | +24.9% | +59.1% | +39.1% |
Range-$308.50M – -$88.70M
CAGR-1.3%
Avg YoY Growth-0.8%
Median YoY Growth+14.5%
Current Streak3 quarters decline
AOCI at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's aoci?
- West Pharmaceutical Services (WST) reported aoci of -$125.20M in Q1 2026.
- How has West Pharmaceutical Services's aoci changed year-over-year?
- West Pharmaceutical Services's aoci increased by 39.1% year-over-year, from -$205.50M to -$125.20M.
- What is the long-term trend for West Pharmaceutical Services's aoci?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's aoci has grown at a -0.9% compound annual growth rate (CAGR), from -$110.60M to -$105.50M.
- What does aoci mean?
- The cumulative total of unrealized gains and losses not yet reflected in net income.